No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
PGEN241220C2000
- 0.00
- 0.000.00%
15min DelayClose Dec 20 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest2.00Strike Price0.00Turnover0.00%IV162.47%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier-1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma15.25Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
No Data
News
Precigen Reports Q3 2024 Financial Results
Precigen (NASDAQ:PGEN Shareholders Incur Further Losses as Stock Declines 13% This Week, Taking Five-year Losses to 86%
Stifel Maintains Precigen(PGEN.US) With Buy Rating, Maintains Target Price $7
Precigen Price Target Maintained With a $4.00/Share by HC Wainwright & Co.
Precigen Analyst Ratings
H.C. Wainwright Maintains Precigen(PGEN.US) With Buy Rating, Maintains Target Price $4